Renaissance Capital BLT Update, page-2

"Benitec Biopharma (BNTC) postponed its IPO, likely reflecting its early stage and a lack of in-human efficacy data."

This is where the confusion starts. Some two bit reporter citing their own non existent reason for the postponement. Firstly, BNTC have announced that will be able to IPO within a certain timeframe. That timeframe has just begun. The reason it is not trading will be paperwork hitches and the agreement being struck. No doubt, the big banks knew of the impending correction.... I have posted that this is coming and the competition is well over priced. This will have some effect..... But apparently the price is set now. If this is correct then we will hear about it Monday. The actual start date for trading is variable but I will bet you will see it trading before any news about a possible viral response. In fact I will not be surprised if they wait until patient seven and eight are eight weeks down the track before they announce anything about possible efficacy.